These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306 [TBL] [Abstract][Full Text] [Related]
27. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Greendyke R; Byrd TF Antimicrob Agents Chemother; 2008 Jun; 52(6):2019-26. PubMed ID: 18378709 [TBL] [Abstract][Full Text] [Related]
28. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study. Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802 [TBL] [Abstract][Full Text] [Related]
29. Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus. Malin JJ; Winter S; van Gumpel E; Plum G; Rybniker J Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427298 [No Abstract] [Full Text] [Related]
30. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments. Entwistle FM; Coote PJ J Med Microbiol; 2018 Apr; 67(4):585-597. PubMed ID: 29458557 [TBL] [Abstract][Full Text] [Related]
31. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. Chu HS; Chang SC; Shen EP; Hu FR PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038 [TBL] [Abstract][Full Text] [Related]
32. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Abshire R; Cockrum P; Crider J; Schlech B Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942 [TBL] [Abstract][Full Text] [Related]
33. Time-kill kinetics of antibiotics active against rapidly growing mycobacteria. Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW J Antimicrob Chemother; 2015 Mar; 70(3):811-7. PubMed ID: 25344808 [TBL] [Abstract][Full Text] [Related]
34. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease? Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864 [TBL] [Abstract][Full Text] [Related]
35. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. Kirkwood ZI; Millar BC; Downey DG; Moore JE Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035 [TBL] [Abstract][Full Text] [Related]
36. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection. Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463 [TBL] [Abstract][Full Text] [Related]
37. A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection. Hirabayashi R; Nakagawa A; Takegawa H; Tomii K BMC Infect Dis; 2019 Aug; 19(1):720. PubMed ID: 31416441 [TBL] [Abstract][Full Text] [Related]
38. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068 [TBL] [Abstract][Full Text] [Related]
39. AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Zhang S; Zou Y; Guo Q; Chen J; Xu L; Wan X; Zhang Z; Li B; Chu H Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482678 [TBL] [Abstract][Full Text] [Related]
40. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Koh WJ; Stout JE; Yew WW Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]